0001127602-21-000254.txt : 20210104 0001127602-21-000254.hdr.sgml : 20210104 20210104192121 ACCESSION NUMBER: 0001127602-21-000254 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210101 FILED AS OF DATE: 20210104 DATE AS OF CHANGE: 20210104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Brien Stephanie Monaghan CENTRAL INDEX KEY: 0001720907 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 21503398 MAIL ADDRESS: STREET 1: C/O MORNINGSIDE TECHNOLOGY ADVISORY, LLC STREET 2: 1188 CENTRE STREET CITY: NEWTON CENTRE STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-01-01 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001720907 O'Brien Stephanie Monaghan C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 Stock Option (Right to Buy) 57.20 2021-01-01 4 A 0 27600 0 A 2030-12-31 Common Stock 27600 27600 D This option was granted 01/01/2021. The option vests quarterly over 1 year on the last day of each quarter from grant date. /s/ David Watson, attorney-in-fact for Stephanie Monagham O'Brien 2021-01-04